Medical update: HER2-positive metastatic breast cancer

 

About 20 percent of breast cancers are HER2 positive, testing positive for a protein called human epidermal growth factor receptor 2, or HER2. In this session, learn about the latest treatment options targeting HER2-positive metastatic breast cancer and hear about research in the pipeline. Get informed about recently approved medicines and how they fit into ongoing treatment.